Wald, David N.

Automated manufacture of autologous CD19 CAR-T cells for treatment of non-hodgkin lymphoma

Jackson, Z., Roe, A., Sharma, A. A., Lopes, F. B. T. P., Talla, A., Kleinsorge-Block, S., Zamborsky, K., Schiavone, J., Manjappa, S., Schauner, R., et al. (2020) · Frontiers in Immunology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 102

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients

Maschan, M., Caimi, P. F., Reese-Koc, J., Sanchez, G. P., Sharma, A. A., Molostova, O., Shelikhova, L., Pershin, D., Stepanov, A., Muzalevskii, Y., et al. (2021) · Nature Communications

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 88

GSK3 is a regulator of RAR-mediated differentiation

Gupta, K., Gulen, F., Sun, L., Aguilera, R., Chakrabarti, A., Kiselar, J., Agarwal, M. K., & Wald, D. N. (2012) · Leukemia

Retinoids in leukemia and cellular processesAcute Myeloid Leukemia Research

Cited by 50

GSK-3 inhibition sensitizes acute myeloid leukemia cells to 1,25D-mediated differentiation

Gupta, K., Stefan, T., Ignatz-Hoover, J., Moreton, S., Parizher, G., Saunthararajah, Y., & Wald, D. N. (2016) · Cancer Research

Vitamin D Research StudiesAcute Myeloid Leukemia Research

Cited by 44

Aberrant GSK3β nuclear localization promotes AML growth and drug resistance

Ignatz-Hoover, J. J., Wang, V., Mackowski, N. M., Roe, A. J., Ghansah, I. K., Ueda, M., Lazarus, H. M., de Lima, M., Paietta, E., Fernandez, H., et al. (2018) · Blood Advances

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments

Cited by 27